Vittoria Biotherapeutics, Inc

Vittoria Biotherapeutics is committed to unlocking the promise of cell therapies while addressing their inherent challenges by strengthening efficacy, improving safety, and broadening therapeutic applicability for patients with difficult-to-treat diseases. An Important Note About Privacy: Vittoria Biotherapeutics is committed to your privacy and will not ask for sensitive personal information such as social security number, date of birth, or bank account details via email, job recruiting, or social media platforms. We do not hire virtually or solicit/interview candidates on Indeed, Telegram, Wire, Google Hangouts or similar public platforms. Any questions about career opportunities can be directed to info@vittoriabio.com

Cart immunotherapy,lymphoma,leukemia,gene editing,cell engineering,cancer,chimeric antigen receptor,cd5,myeloma,t cells,hematology,crispr,crispr-cas9,biotherapeutics,patient,physician,shp-1,cd2,cd7,cd30,and diagnosis

Vittoria biotherapeutics, inc operates in the Biotechnology research industry.

Vittoria biotherapeutics, inc's revenue is 11m - 100m

Vittoria biotherapeutics, inc has 11 - 50 employees.